Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realise the new science’s promise by bringing safe, effective medicines from lab to manufacturing plant to patient.
Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people’s lives.
Amgen’s manufacturing operation in Dun Laoghaire Co Dublin was established in May 2011 and currently employs around 300 people, The site is currently undergoing a €200 million plus expansion, which includes the construction of an approximately 11,700 square metres building extension, new production plant and expanded warehouse. In addition, a significant research and development investment will also see the Dun Laoghaire facility undergo a major technology process enhancement to transform the plant into one of the leading biotechnology manufacturing sites in the world. As Amgen expands internationally, Dun Laoghaire will enhance its global production capability, ensuring continuity of supply of Amgen medicines for seriously ill patients worldwide. The company’s Irish commercial office is located in Santry, Co Dublin.